Latest Takeda Pharmaceutical Company Stories
KYOTO and OSAKA, Japan, April 16, 2015 /PRNewswire/ -- Center for iPS Cell Research Application (CiRA) of Kyoto University and Takeda Pharmaceutical Company Limited (Takeda) announced today
DUBLIN, April 14, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/2tn7dq/global) has announced the addition of the "Global Nanomedicine
PHILADELPHIA, April 6, 2015 /PRNewswire-USNewswire/ -- The Sheller, P.C. law firm is investigating cancer in patients who took the Type 2 diabetes drug ACTOS.
RnRMarketResearch.com adds "Male and Women Infertility - Pipeline Review, H1 2015" to its store.
NEW YORK, March 12, 2015 /PRNewswire/ -- AbbVie's recent acquisition of Pharmacyclics for $21 billion strengthens AbbVie's already comprehensive pipeline and increases the company's growth prospects,
NEW YORK, March 9, 2015 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") today held a briefing for investors and analysts in New York, discussing the company's gastroenterology
The $1.3 million in punitive damages is in addition to a $2.3 million award to the plaintiff, who alleges that Actos caused him to develop bladder cancer.
Plaintiff alleged his bladder cancer is the result of his taking Actos and that he underwent bladder removal due to his bladder cancer diagnosis. Port Washington,
ReportsnReports.com adds “Brain Cancer - Pipeline Review, H1 2015” to its store.